Pfizer to buy Allergan for more than $ 150 billion

Pfizer secured formal approval from its Board on Sunday for the acquisition of Botox's manufacturer, Allergan, for more than 150 billion dollars, a deal that will create the world's largest drug company, according to people familiar with the matter.
The deal, the biggest in history in the health care sector, will be announced on Monday and should attract the political wrath in a presidential election year in the United States, because Pfizer would change your address to Ireland, where the Allergan is recorded, in a so-called "reversal" that would reduce its corporate tax rate.
The deal also would restart the debate on pharmaceutical industry about the role of research and development, once Chief Executive of Allergan, Brent Saunders, prolific negotiator of agreements and skeptical about the discovery of medicines, would the combined company in a position to influence its strategy.
ADVERTISEMENT
With the deal, Pfizer would pay with 11.3 of its shares for each role of Allergan, claimed the sources. Also there would be a small cash component, accounting for less than 10% of the value of the transaction, according to people.
The Chief Executive of Pfizer, Ian Read, 62 years old, will be Chief Executive of the combined company, with the Chief Executive of Allergan, Brent Saunders, of 45 years, serving in a senior role and focused on operations and integration, added the sources.